Correction to: Rheumatol Ther https://doi.org/10.1007/s40744-021-00361-5
In the original article published, there is an error in the video of the supplementary material. The correct supplementary material has been updated.
The original article has been corrected.
Author information
Authors and Affiliations
Consortia
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary file1 (WMV 212490 kb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Rehberg, M., Giegerich, C., Praestgaard, A. et al. Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data. Rheumatol Ther 8, 1921–1922 (2021). https://doi.org/10.1007/s40744-021-00389-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40744-021-00389-7